Healthcare provider profile · identity verified

Brock W. Millet, M.D.

Family Practice · COQUILLE, OR · NPI 1265758973

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	276	67
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	264	46
Hydrochlorothiazide	Hydrochlorothiazide	261	76
Atorvastatin Calcium	Atorvastatin Calcium	254	70
Lisinopril	Lisinopril	254	69
Losartan Potassium	Losartan Potassium	239	60
Omeprazole	Omeprazole	201	52
Furosemide	Furosemide	189	59
Metoprolol Tartrate	Metoprolol Tartrate	185	52
Gabapentin	Gabapentin	169	47
Eliquis	Apixaban	145	32
Amlodipine Besylate	Amlodipine Besylate	143	49
Metoprolol Succinate	Metoprolol Succinate	139	43
Trazodone Hcl	Trazodone Hcl	137	24
Fluoxetine Hcl	Fluoxetine Hcl	136	27
Potassium Chloride	Potassium Chloride	129	35
Tamsulosin Hcl	Tamsulosin Hcl	119	40
Metformin Hcl	Metformin Hcl	113	30
Simvastatin	Simvastatin	110	30
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	108	31
Carvedilol	Carvedilol	104	28
Glipizide	Glipizide	102	22
Albuterol Sulfate Hfa	Albuterol Sulfate	91	34
Oxycodone Hcl	Oxycodone Hcl	86	15
Alprazolam	Alprazolam	84	14
Tramadol Hcl	Tramadol Hcl	78	23
Duloxetine Hcl	Duloxetine Hcl	76	18
Pantoprazole Sodium	Pantoprazole Sodium	75	23
Prednisone	Prednisone	73	27
Azithromycin	Azithromycin	67	55
Pregabalin	Pregabalin	60	14
Zolpidem Tartrate	Zolpidem Tartrate	59	11
Lorazepam	Lorazepam	58	18
Clopidogrel	Clopidogrel Bisulfate	56	15
Baclofen	Baclofen	55	suppressed
Meloxicam	Meloxicam	55	20
Sertraline Hcl	Sertraline Hcl	54	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	53	13
Bupropion Xl	Bupropion Hcl	52	11
Quetiapine Fumarate	Quetiapine Fumarate	51	suppressed
Atenolol	Atenolol	50	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	48	35
Fluticasone Propionate	Fluticasone Propionate	44	15
Allopurinol	Allopurinol	40	12
Synthroid	Levothyroxine Sodium	40	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	39	suppressed
Celecoxib	Celecoxib	38	12
Ibuprofen	Ibuprofen	38	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	12
Donepezil Hcl	Donepezil Hcl	37	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	36	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	33	27
Pravastatin Sodium	Pravastatin Sodium	32	suppressed
Propranolol Hcl	Propranolol Hcl	32	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Clonazepam	Clonazepam	31	suppressed
Ventolin Hfa	Albuterol Sulfate	31	12
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Diazepam	Diazepam	29	suppressed
Lovastatin	Lovastatin	29	suppressed
Montelukast Sodium	Montelukast Sodium	29	suppressed
Ozempic	Semaglutide	28	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	suppressed
Digoxin	Digoxin	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	23
Glipizide Er	Glipizide	25	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	15
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Fluconazole	Fluconazole	21	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	21
Arnuity Ellipta	Fluticasone Furoate	20	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Finasteride	Finasteride	20	suppressed
Ketoconazole	Ketoconazole	20	12
Lamotrigine	Lamotrigine	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	12
Buspirone Hcl	Buspirone Hcl	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Estradiol	Estradiol	18	suppressed
Nitroglycerin	Nitroglycerin	18	13
Ranolazine Er	Ranolazine	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Indomethacin	Indomethacin	17	11
Methotrexate	Methotrexate Sodium	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Glimepiride	Glimepiride	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Morphine Sulfate	Morphine Sulfate	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Nyamyc	Nystatin	15	suppressed
Nystatin	Nystatin	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Prazosin Hcl	Prazosin Hcl	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Carisoprodol	Carisoprodol	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Enbrel Sureclick	Etanercept	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Probenecid-Colchicine	Probenecid/Colchicine	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Famotidine	Famotidine	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error